LVP software of the Ivenix Infusion System (IIS); LVP-SW-0004

FDA Device Recall #Z-1283-2024 — Class II — May 10, 2023

Recall Summary

Recall Number Z-1283-2024
Classification Class II — Moderate risk
Date Initiated May 10, 2023
Status Completed
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Fresenius Kabi USA, LLC
Location North Andover, MA
Product Type Devices
Quantity 6 US

Product Description

LVP software of the Ivenix Infusion System (IIS); LVP-SW-0004

Reason for Recall

Retroactively reported corrections from 2023: 1) A software defect may cause an incorrect (Fail-Stop) alarm when an administration set is loaded or coupled while the pump is executing the power-up sequence. May lead to delay in therapy. 2) Alert is not annunciated informing the clinician that the bolus cannot be delivered when the entered bolus dose exceeds the Care Profile Hard Rate Max limit and Rapid Bolus is selected. May lead to over infusion. Both issues were resolved in all fielded product in software version 5.8.0, which was installed in affected units May thru August 2023.

Distribution Pattern

US Nationwide distribution to the states of CA, CO, NJ, WI, UT.

Lot / Code Information

UDI-DI 00811505030122 Software versions 5.2.1/5.2.2

Other Recalls from Fresenius Kabi USA, LLC

Recall # Classification Product Date
Z-1048-2026 Class II Ivenix Infusion System (IIS), LVP Software: LVP... Nov 21, 2025
Z-0885-2026 Class I Ivenix Infusion System (IIS), LVP Software LVP-... Nov 14, 2025
Z-0848-2026 Class II Ivenix Infusion System (IIS), Large Volume Pump... Nov 3, 2025
Z-0586-2026 Class I IVENIX INFUSION SYSTEM, LVP Primary Administrat... Nov 3, 2025
Z-0378-2026 Class II Ivenix Infusion System (IIS), Large Volume Pump... Sep 3, 2025

Frequently Asked Questions

A software recall means the device's embedded software or firmware has a defect that could affect its performance or safety. Many software recalls are corrected through firmware updates that can be applied without physically replacing the device. For implantable devices, the update may be delivered wirelessly during a routine clinic visit. For external devices, the manufacturer may provide updated software files or replacement units. Contact your healthcare provider to determine whether your specific device and software version are affected and what action is recommended.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.